ARCHIVES

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Free Standing Cancer Center Firms Expanding Markets

February 21, 1986

In Brief: Leonidas Platanias named director of Lurie Comprehensive Cancer Center

October 3, 2014

Pazdur Waxes On Calumet City And Krebiozen; Parkinson Takes Interim CMO Job at Zyngenia

April 27, 2012

New NCAB Chair Seeks Ideas, Opinions On Cancer Priorities

September 23, 1994

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

June 4, 1993